MULTIFAMILY MONDAY

Just as the Dow reported a 28-month high, Massey Knakal had its own busiest month in almost three years, closing 35 transactions for an aggregate $221M in December. And premium pricing is being achieved for core assets, reports the firm’s partner James Nelson, who will be speaking on the capital markets during Bisnow’sMultifamily Summit this coming Friday at the Roosevelt Hotel.
One of the Massey Knakal's recent transactions includes a multifamily portfolio of four buildings in Astoria, totaling 220 units, which sold for $30.1M cash and closed in six days. A lack of supply has held up pricing, James notes—in Q3 ’08, the firm had close to750 listings, and today, it has fewer than 550. There’s also been an uptick in loan and REO offerings, which has more than doubled to12% of Massey Knakal’s inventory since last year and should continue into this year. To hear more, join James and top market experts like Ackman-Ziff’s Pat Hanlon, Meridian Capital Group’sRalph Herzka, Freddie Mac’s Mike Edelman, Abacus Capital Group’s Benjamin Freidman, and more. Plenty of schmoozing timetoo! Register here.

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's New York Newsletters
Related Stories

1,300 Projects Potentially Paused Due To Suspension Of Quality Inspectors

Walker & Dunlop On Why The Housing Market Is More Balanced Than It Appears

Mamdani Administration Applauds Transfer Of 3 Distressed Rent-Stabilized Buildings

What New York Can Learn From California's Push To Cut Environmental Red Tape

California Duo's Ponzi-Like Investment Scheme Unravels With Bankruptcy, SEC Charges

Prominent Philly Caterer Sues Town Officials Over Vineyard Plans In Bucks County

Houston Firm Hires Former Floor & Decor Exec As President Of New Offering

Related Signs First Tenants At Madison Avenue Tower: The N.Y. Deal Sheet

Deutsche Finance Alleges BVK Is Responsible For CRE Portfolio Losing $1B In New Lawsuit

'This Is A Big Change For Me': Leslie Cohen Launching New Company After Leaving Davis Cos.

The Pain In NYC's Biotech Market Is Hitting Harlem Hardest

Law Firms Are On A Historic Office Binge